Remove companies glaukos-corp
article thumbnail

Ivantis To Pay $60M To End Patent Fight Over Glaucoma Tech

IP Law 360

Glaukos Corp. have inked a $60 million deal to end their patent dispute over therapies for treating glaucoma, the companies announced Wednesday. and Ivantis Inc.

Patent 40